Evidence map›Paper›PMID 37344439›Full record

ArticleInternal medicine (Tokyo, Japan)2024

A Successfully Treated Case of Posterior Ischemic Optic Neuropathy That Developed during Antihypertensive Therapy for Hypertensive Emergency.

Yuta Yonezawa, Kenichi Koga, Yoshiaki Higashi, Masako Hasebe, Chiho Fukushima, Chiaki Omiya, Keisuke Nishioka, Kensei Yahata

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yuta YonezawaDepartment of Nephrology, Osaka Red Cross Hospital, Japan.
Kenichi KogaDepartment of Nephrology, Osaka Red Cross Hospital, Japan.
Yoshiaki HigashiDepartment of Nephrology, Osaka Red Cross Hospital, Japan.
Masako HasebeDepartment of Nephrology, Osaka Red Cross Hospital, Japan.
Chiho FukushimaDepartment of Nephrology, Osaka Red Cross Hospital, Japan.
Chiaki OmiyaDepartment of Nephrology, Osaka Red Cross Hospital, Japan.
Keisuke NishiokaDepartment of Nephrology, Osaka Red Cross Hospital, Japan.
Kensei YahataDepartment of Nephrology, Osaka Red Cross Hospital, Japan.
Osaka Red Cross Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 33-year-old woman developed hypertensive emergency (268/168 mmHg) with renal failure and hypertensive retinopathy. Four hours after the initiation of antihypertensive therapy with the continuous infusion of nicardipine, her blood pressure (BP) decreased to 168/84 mmHg; however, the patient developed blindness. She was diagnosed with posterior ischemic optic neuropathy (PION). Her BP was maintained at approximately 175/90 mmHg until her vision improved. Olmesartan was initiated on day 13, and her BP decreased to approximately 135/95 mmHg without the re-exacerbation of vision loss. Although the prognosis of PION is poor, its early diagnosis and gradual antihypertensive therapy may help preserve the patient's vision.

Indexed as

Hypertensive CrisisOptic Neuropathy, IschemicAdultAntihypertensive AgentsBlood PressureFemaleHumansAntihypertensive Agentsantihypertensive therapyhypertensive emergencyposterior ischemic optic neuropathyrenin-angiotensin system inhibitors

Identifiers

PMID37344439
PMCPMC10937120
OpenAlexW4381435151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.